• Affiliate Associate Professor, Global Health
Javier Lama

IMPACTA PERU Clinical Trials Unit
Asociacion Civil Impacta Salud y Educacion
Av. Almirante Miguel Grau No. 1010
Lima 4, Peru

Phone Number: 
Select from the following:

Dr. Javier R. Lama is a Specialist in Infectious and Tropical Diseases, who in 2004, earned a Master in Public Health´s Degree and a Certificate of International Health at University of Washington. Dr. Lama is the Principal Investigator of the US NIH/NIAID funded IMPACTA PERU Clinical Trials Unit, whose overarching goal is to contribute to the design and implementation of clinical research, across the continuum from prevention to treatment, to decrease new HIV infections, reduce HIV associated co-morbidity and mortality, and ultimately end the HIV epidemic.

During the last 20 years, Dr. Lama has collaborated and led planning, designing, implementing and managing multi-disciplinary clinical research to better understand the basics and optimize the prevention and treatment of HIV, tuberculosis and sexually transmitted infections. He has assisted multiple staff members with the preparation of research grants and protocol implementation in the sites under his leadership. Dr. Lama has also mentored and co-mentored different pre- and post-doctoral students from different Peruvian and American academic institutions by involving them in his research activities.

  • MD (Universidad Peruana Cayetano Heredia)
  • MPH (University of Washington)
Country Affiliations 
  • Spanish
Health Topics 
  • Clinical Mentoring
  • Drug and Vaccine Development
  • Epidemiology
  • Health Interventions
  • Hepatitis
  • HIV Transmission
  • Implementation Science
  • Infectious Diseases
  • Operations Research
  • Prevention
  • STDs (other than HIV)
  • TB
  • Tobacco, Alcohol, and Drug Use
  • Transgender Health

Patient-oriented research, epidemiological and behavioral studies, and outcomes and health services research focused on the prevention and treatment of HIV, tuberculosis and sexually transmitted infections


Perez-Brumer AG, Oldenburg CE, Segura ER, Sanchez J, Lama JR, Clark JL. Anonymous partnerships among MSM and transgender women (TW) recently diagnosed with HIV and other STIs in Lima, Peru: an individual-level and dyad-level analysis. Sex Transm Infect. 2016 Feb 24. [Epub ahead of print] PubMed PMID: 26912910.

Blair CS, Segura ER, Perez-Brumer AG, Sanchez J, Lama JR, Clark JL. Sexual orientation, gender identity and perceived source of infection among men who have sex with men (MSM) and transgender women (TW) recently diagnosed with HIV and/or STI in Lima, Peru. AIDS Behav. 2016 Jan 14. [Epub ahead of print] PubMed PMID: 26767533.

Tang EC, Galea JT, Kinsler JJ, Gonzales P, Sobieszczyk ME, Sanchez J, Lama JR. Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men. Sex Transm Infect. 2016 May; 92(3):200-5. PubMed PMID: 26574569.

Tang EC, Segura ER, Clark JL, Sanchez J, Lama JR. The syphilis care cascade: tracking the course of care after screening positive among men and transgender women who have sex with men in Lima, Peru. BMJ Open. 2015 Sep 18; 5(9):e008552. PubMed PMID: 26384725.

Mayer KH, Bekker LG, Stall R, Grulich AE, Colfax G, Lama JR. Comprehensive clinical care for men who have sex with men: an integrated approach. Lancet. 2012 Jul 28; 380(9839):378-87. PubMed PMID: 22819653.